Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Session: New Antimicrobials in the Pipeline

51 - Pritelivir, a nonnucleoside helicase-primase inhibitor, for the treatment of herpes simplex virus (HSV) infections in Phase 3 clinical development.

Monday, October 20, 2025
8:48 AM - 9:00 AM US ET
Location: B302-B304
Disclosure(s):
Alexander Birkmann, PhD: AiCuris Anti-Infectives Cures AG: Employee, Stocks/Bonds (Private Company)